ArticleOncotarget2016

Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma.

Xiaoyan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.